Chirurgische und medikamentöse Therapie der gastroösophagealen Refluxkrankheit

Einleitung

Der nachfolgende Text wurde im Rahmen einer Pro- und Contra-Diskussion anlässlich der 57. Tagung der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (Präsident: Prof. Dr. Sauerbruch; Bonn, 14.9.2002) entwickelt. Die Aussagen unter den neun Konsenspunkten sind mit den aus Sicht der Autoren vorliegenden Evidenzgraden und den dazu ausschlaggebenden Literaturstellen aufgeführt (Evidenzgrade I-IV, Erklärung siehe unten). Das Literaturverzeichnis ist bis zum Februar 2003 nachgeführt worden.

Es werden folgende Abkürzungen verwendet:

C: chirurgische Antirefluxtherapie, M: medikamentöse Antirefluxtherapie.

Literatur

• 1 Dent J, Brun J, Fendrick A M. et al. On behalf of the Genval Workshop Group. . An evidence-based appraisal of reflux disease management - the Genval Workshop Report.  Gut. 1999;  44 (Suppl 2) 1-16
• 2 Inadomi J M, Jamal R, Murata G H. et al . Step-down management of gastroesophageal reflux disease.  Gastroenterology. 2001;  121 (5) 1095-1100
• 3 Edwards S J, Lind T, Lundell L. Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis.  Aliment Phamacol Ther. 2001;  15 1729-1736
• 4 Thjodleifsson B, Rindi G, Fiocca R. et al . A randomized double blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years.  Aliment Pharmacol Ther. 2003;  17 343-351
• 5 Van der Peet D L, Klinkenberg-Knol E C, Eijsbouts Q AJ. et al . Laparoscopic Nissen fundoplication for the treatment of gastroesophageal reflux disease (GERD); surgery after extensive conservative treatment.  Surg Endosc. 1998;  1 1159-1161
• 6 Campos G M, Peters J H, DeMeester T R. et al . Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.  J Gastrointest Surg. 1999;  3 (3) 292-300
• 7 Kahrilas P J. Management of GERD: Medical versus surgical.  Seminars in Gastrointestinal Disease. 2001a;  12 3-15
• 8 Kahrilas P J. Surgical therapy for reflux disease.  JAMA. 2001b;  2376-2378
• 9 Galmiche J P, Zerbib F. Antagonist. Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease.  Gut. 2002;  51 472-474
• 10 Lundell L. Protagonist. Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease.  Gut. 2002;  51 468-471
• 11 Parilla P, de Martinez Haro LF, Ortiz A. et al . Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus.  Ann Surg. 2003;  237 291-298
• 12 Peghini P G, Katz P O, Castell D O. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects.  Gastroenterology. 1998;  115 (6) 1335-1339
• 13 Farrell T M, Richardson W S, Trus T L. et al . Response of atypical symptoms of gastro-oesophageal reflux to antireflux surgery.  Br J Surg. 2001;  88 (12) 1649-1652
• 14 Amin M R, Postma G N, Johnson P. et al . Proton pump inhibitor resistance in the treatment of laryngopharygeal reflux.  Otolaryngol Head Neck Surg. 2001;  125 374-378
• 15 Reilly J P. Safety profile of the proton-pump inhibitors.  Am J Health Syst Pharm. 1999;  56 (23, Suppl 4) S11-17
• 16 Gerson L B, Hatton B N, Ryono R. et al . Clinical and fiscal impact of lansoprazole intolerance in veterans with gastro-oesophageal reflux disease.  Aliment Pharmacol Ther. 2000;  4 (4) 397-406
• 17 Cordes A, Vogt W, Maier K P. Pantozol-induzierte Hepatitis.  Dtsch Med Wochenschr. 2003;  128 611-614
• 18 Hungin A P, Rubin G, O'Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice.  Br J Gen Pract. 1999;  49 (443) 463-464
• 19 Dent J. Controversies in long-term management of reflux disease.  Baillère’s Clinical Gastroenterology. 2000;  14 811-826
• 20 Romagnuolo J, Meier M A, Sadowski D C. Medical or surgical therapy for erosive reflux esophagitis: cost utility analysis using a Markov model.  Ann Surg. 2002;  236 (2) 191-202
• 21 O’Boyle C J, Watson D I, DeBeaux A C. et al . Preoperative prediction of long-term outcome following laparoscopic fundoplication.  ANZ J Surg. 2002;  2 471-475
• 22 Granderath F A, Kamolz T, Schweiger U M. et al . Outcome after laparoscopic antireflux surgery: fundoplication and re-fundoplication in the elderly.  Chirurg. 2001;  72 (9) 1026-1031
• 23 Klinkenberg-Knol E C, Festen H P, Jansen J B. et al . Long term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.  Ann Intern Med. 1994;  121 (3) 161-167
• 24 Klinkenberg-Knol E C, Nelis F, Dent J. et al . Long term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.  Gastroenterology. 2000;  118 (4) 661-669
• 25 Peters F T, Ganesh S, Kuipers E J. et al . Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study.  Gut. 1999;  45 489-494
• 26 Vela M F, Camacho Lobato  L, Srinivasan R. et al . Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole.  Gastroenterology. 2001;  120 (7) 1599-1606
• 27 Lundell L, Miettinen P, Myrvold H E. et al . Continued (5 year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.  J Am Coll Surg. 2001;  192 172-181
• 28 Taha A S, Angerson W J, Morran C G. Reflux and Barrett’s oesophagitis after gastric surgery - long-term follow-up and implications for the roles of gastric acid and bile in oesophagitis.  Aliment Pharmacol Ther. 2003;  17 547-552
• 29 Ortiz A, de Martinez H aro LF, Parrilla P. et al . Conservative treatment versus antireflux surgery in Barrett’s oesophagus: long term results of a prospective study.  Br J Surg. 1996;  83 (2) 274-278
• 30 Spechler S J, Lee E, Ahnen D. et al . Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.  JAMA. 2001;  285 2331-2338
• 31 Ye W, Chow W H, Lagergren J. et al . Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery.  Gastroenterology. 2001;  121 (6) 1286-1293
• 32 Klaus A, Hinder R A. Medical therapy versus antireflux surgery in Barrett’s esophagus: what is the best therapeutic approach?.  Dig Dis. 2000-2001;  18 224-231
• 33 Gutschow C A, Schröder W, Prenzel K. et al . Impact of antireflux surgery on Barrett’s esophagus.  Langenbecks Arch Surg. 2002;  387 3 - 4; 138 - 145
• 34 P van, Numans M E, Bonis P A. et al . Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.  Cochrane Database Syst Rev. 2001;  4 CD002095
• 35 Basu K K, Bale R, West K P. et al . Persistent acid reflux and symptoms in patients with Barrett’s oesophagus on proton-pump inhibitor therapy.  Eur J Gastroenterol Hepatol. 2002;  14 (11) 1187-1192
• 36 You J H, Lee A C, Wong S C. et al . Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis.  Aliment Pharmacol Ther. 2003;  17 785-792
• 37 Leeder P C, Watson D I, Jamieson G G. Laparoscopic fundoplication for patients with symptoms but no objective evidence of gastroesophageal reflux.  Dis Esoph. 2002;  15 (4) 309-314
• 38 Maziak D E, Todd T RJ, Pearson F G. Massive hiatus hernia: evaluation and surgical management.  J Thorac Cardiovasc Surg. 1998;  115 53-62
• 39 van Herwaarden M A, Samsom M, Smout A J. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations.  Gastroenterology. 2000;  119 (6) 1439-1446
• 40 Jones M P, Sloan S S, Rabine J C. et al . Hiatal hernia size is the dominant determinant of esophagitis presence and severity of gastroesophageal reflux disease.  Am J Gastroenterol. 2001;  96 1711-1717
• 41 Avidan B, Sonnenberg A, Schnell T G. et al . Hiatal hernia size, Barrett’s length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.  Am J Gastroenterol. 2002;  97 (8) 1930-1936
• 42 Stylopoulos N, Gazelle G S, Rattner D W. Paraesophageal hernias: operation or observation.  Ann Surg. 2002;  236 492-501
• 43 Kleinmann E, Halbfass H J. Zur Problematik des „short esophagus” in der laparoskopischen Antirefluxchirurgie.  Chirurg. 2001;  72 408-413
• 44 Streets C G, DeMeester S R, DeMeester T R. et al . Excellent quality of life after Nissen fundoplication depends on successful elimination of reflux symptoms and not the invasiveness of the surgical approach.  Ann Thorac Surg. 2002;  74 (4) 1019-1024; discussion 1024-1025
• 45 Deschamps C, Allen M S, Trastek V F. et al . Early experience and learning curve associated with laparoscopic Nissen fundoplication.  J Thorac Cardiovasc Surg. 1998;  115 281-284
• 46 Rantanen T K, Halme T V, Luostarinen M E. et al . The long term results of open antireflux surgery in a community-based health care center.  Am J Gastroenterol. 1999;  94 1777-1781
• 47 Rydberg L, Ruth M, Abrahamsson H. et al . Tailoring antireflux surgery: A randomized clinical trial.  World J Surg. 1999;  23 612-618
• 48 Csendes A, Burdiles P, Korn O. et al . Late results of a randomized clinical trial comparing total fundoplication versus calibration of the cardia with posterior gastropexy.  Br J Surg. 2000;  87 (3) 289-297
• 49 Bais J E, Bartelsman J F, Bonjer H J. et al . Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group.  Lancet. 2000;  355 170-174
• 50 Hagedorn C, Lonroth H, Rydberg L. et al . Long-term efficacy of total (Nissen-Rossetti) and posterior partial (Toupet) fundoplication. Results of a randomized clinical trial.  J Gastrointest Surg. 2002;  31 (6) (4) 540-545
• 51 Hüttl T P, Hohle M, Meyer G. et al . Antireflux surgery in Germany. Results of a representative survey with analysis of 2,540 antireflux operations.  Chirurg. 2002;  73 (5) 451-461
• 52 Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a U.S. community.  Am J Med. 2003;  1114 1-5
• 53 Tan L C, Samanta S, Hosking S W. Safe transition from open to laparascopic fundoplication by an established consultant - the importance of repeated audit.  Ann R Coll Surg Engl. 2002;  84 84-88
• 54 Menon V S, Manson J M, Baxter J N. Laparascopic fundoplication: learning curve and patient satisfaction.  Ann R Coll Surg Engl. 2003;  85 10-13
• 55 Fibbe C, Layer P, Keller J. et al . Esophageal motility in reflux disease before and after fundoplication: A prospective, randomized, clinical, and manometric study.  Gastroenterology. 2001;  121 (1) 5-14
• 56 Avidan B, Sonnenberg A, Schnell T G. et al . There are no reliable symptoms for erosive oesophagitis and Barrett’s oesophagus: endoscopic diagnosis is still essential.  Aliment Pharmacol Ther. 2002;  16 735-742
• 57 Khajanchee Y S, O’Rourke R W, Lockhart B. et al . Postoperative symptoms and failure after antireflux surgery.  Arch Surg. 2002;  137 1008-1013
• 58 Blom D, Peters J H, DeMeester T R. et al . Physiologic mechanism and preoperative prediction of new-onset dysphagia after laparoscopic Nissen fundoplication.  J Gastrointest Surg. 2002;  6: (1) 22-27; discussion 27-28
• 59 Booth M, Stratford J, Dehn T C. Preoperative esophageal body motility does not influence the outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease.  Dis Esophagus. 2002;  15 (1) 57-60
• 60 Martinez S D, Malagon I B, Garewal H S. et al . Non-erosive reflux disease (NERD) - acid reflux and symptom patterns.  Aliment Phamacol Ther. 2003;  17 537-545
• 61 Van der Burgh A, Dees J, Hop W C. et al . Oesophageal cancer is an uncommon cause of death in patients with Barrett’s oesophagus.  GUT. 1996;  39 5-8
• 62 Sampliner R E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. The Practice Parameters Committee of the American College of Gastroenterology.  Am J Gastroenterol. 1998;  93 (7) 1028-1032
• 63 MacDonald C E, Wicks A C, Playford R J. Final results from 10 year cohort of patients undergoing surveillance for Barrett’s oesophagus. Observational study.  Br Med J. 2000;  321 1252-1255
• 64 Sontag S J. Preventing death of Barrett’s cancer: does frequent surveillance endoscopy do it?.  Am J Med. 2001;  3 (111 Suppl 8A) 137S-141
• 65 Corley D A, Levin T R, Habel L A. et al . Surveillance and survival in Barrett’s adenocarcinoma; a population-based study.  Gastroenterology. 2002;  122 633-640
• 66 Parrilla P, de Martinez Haro  LF, Ortiz A. et al . Standard antireflux operations in patients who have Barrett’s esophagus. Current results.  Chest Surg Clin N Am. 2002;  12 113-126
• 67 Carlson M A, Frantzides C T. Complications and results of primary minimally invasive antireflux procedures: a review of 10,735 reported cases.  J Am Coll Surg. 2001;  193 (4) 428-439
• 68 Schäfer H, Collet P, Wolfgarten E. et al . Endoskopische Gastroplastik zur Behandlung der gastroösophagealen Refluxerkrankung - eine Pilotstudie.  Visceralchirurgie. 2001;  36 362-366
• 69 Devière J, Pastorelli A, Louis H. et al . Endoscopic implantation of a biopolymer in the lower esophageal sphincter for gastroesophageal reflux: a pilot study.  Gastrointest Endosc. 2002;  55 (3) 335-341
• 70 Triadafilopoulos G, DiBaise J K, Nostrant T T. et al . The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial.  Gastrointest Endosc. 2002;  55 (2) 149-156
• 71 Wolfsen H C, Richards W O. The Stretta procedure for the treatment of GERD: a registry of 558 patients.  J Laparoendosc Adv Surg Tech. 2002;  12 395-402
• 72 Mahmood Z, McMahon B P, Arfin Q. et al . Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up.  Gut. 2003;  52 (1) 34-39
• 73 Peters J H, Silverman D E, Stein A. Lower esophageal sphincter injection of a biocompatible polymer.  Surg Endosc. 2003;  17 (4) 547-550
• 74 Heudebert G R, Marks R, Wilcox M. et al . Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis.  Gastroenterology. 1997;  112 1078-1086
• 75 Myrvold H E, Lundell L, Miettinen P. et al and the Nordic GORD Study Group. . The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery.  Gut. 2001;  49 (4) 488-494
• 76 O’Connor J B, Provenzale D, Brazer S. Economic considerations in the treatment of gastroesophageal reflux disease: a review.  Am J Gastroenterol. 2000;  95 (12) 3356-3364
• 77 Sonnenberg A. Motion - laparoscopic Nissen fundoplication is more cost effective than oral PPI administration: arguments against the motion.  Can J Gastroenterol. 2002;  16 627-631
• 78 Swanström L L. Motion - laparoscopic Nissen fundoplication is more cost effective than oral PPI administration: arguments for the motion.  Can J Gastroenterol. 2002;  16 621-623
• 79 Hadorn D C, Baker D. Development of the AHCPR-sponsored heart failure guideline: methodologic and procedural issues.  Jt Comm J Qual Improv. 1994;  20 539-547
• 80 Bollschweiler E. Nationale und klinikinterne Leitlinien: Definition und Problemlage. Lauterbach KW, Schrappe M Gesundheitsökonomie, Qualitätsmanagement und Evidence-based Medicine Stuttgart; Schattauer-Verlag 2001: 457-462